Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Genomics

HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONR
March 19, 2020
From left, Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight coronavirus at the University of Minnesota
From left, Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist Cody Hoffmann watch an automated liquid handler run through it paces at the University of Minnesota Genomics Center as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONP
March 19, 2020
From left; Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight cornovirus at the University of Minnesota
From left; Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist Cody Hoffmann in their new lab that is being transformed to fight the coronavirus at the University of Minnesota Genomics Center as a trial begins to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of coronavirus disease (COVID-19) at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONO
March 19, 2020
Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight coronavirus at the University of Minnesota
Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
BRITAIN-ELECTION/
RTS2TO5B
October 31, 2019
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO51
October 31, 2019
British Prime Minister Boris Johnson, gestures as he speaks to staff at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson, gestures as he speaks to staff at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO4N
October 31, 2019
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at East Midlands and East...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO4F
October 31, 2019
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO40
October 31, 2019
British Prime Minister Boris Johnson gestures as he speaks to Professor Rebecca Fitzgerald who helped...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson gestures as he speaks to Professor Rebecca Fitzgerald who helped develop the Cytosponge at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO3R
October 31, 2019
British Prime Minister Boris Johnson speaks to outpatient Kathy Power at the East Midlands and East of...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to outpatient Kathy Power at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNYO
October 31, 2019
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNYG
October 31, 2019
British Prime Minister Boris Johnson speaks to Professor Rebecca Fitzgerald who helped develop the Cyptosponge...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to Professor Rebecca Fitzgerald who helped develop the Cyptosponge at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNXK
October 31, 2019
British Prime Minister Boris Johnson speaks to Dr Sarah Bowdin at the East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to Dr Sarah Bowdin at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNXG
October 31, 2019
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at the East Midlands and...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNX9
October 31, 2019
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNX5
October 31, 2019
British Prime Minister Boris Johnson greets and speaks to nurses at the East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson greets and speaks to nurses at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNX4
October 31, 2019
British Prime Minister Boris Johnson speaks to nurses at the East Midlands and East of England Genomic...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to nurses at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
CHINA-PETCLONING/
RTX6IWHM
December 17, 2018
A technician works with genome samples at a lab of the biotech company Sinogene that specialises in dog...
Beijing, China
A technician works with genome samples at a lab of the biotech company Sinogene in Beijing
A technician works with genome samples at a lab of the biotech company Sinogene that specialises in dog cloning, in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas Peter
GENOMICS-TUMOR/
RTX6I6AB
December 11, 2018
Natan prepares to take his medication given to by his mother Reuters U.S. Health Editor Michele Gershberg...
New York, UNITED STATES
Natan prepares to take his medication given to by his mother Reuters U.S. Health Editor Michele Gershberg...
Natan prepares to take his medication given to by his mother Reuters U.S. Health Editor Michele Gershberg in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTX6I6A9
December 11, 2018
Natan son of Reuters U.S. Health Editor Michele Gershberg plays catch with his brother in the Brooklyn...
New York, UNITED STATES
Natan son of Reuters U.S. Health Editor Michele Gershberg plays catch with his brother in New York
Natan son of Reuters U.S. Health Editor Michele Gershberg plays catch with his brother in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTX6I6A5
December 11, 2018
Natan is given his medication from his mother Reuters U.S. Health Editor Michele Gershberg with encouragement...
New York, UNITED STATES
Natan is given his medication from his mother Reuters U.S. Health Editor Michele Gershberg with encouragement...
Natan is given his medication from his mother Reuters U.S. Health Editor Michele Gershberg with encouragement from his brother in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTX6I69Y
December 11, 2018
Natan, is pushed on a swing by his mother Reuters U.S. Health Editor Michele Gershberg, at a park in...
New York, UNITED STATES
Natan, is pushed on a swing by his mother Reuters U.S. Health Editor Michele Gershberg, at a park in...
Natan, is pushed on a swing by his mother Reuters U.S. Health Editor Michele Gershberg, at a park in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTX6I69V
December 11, 2018
Reuters U.S. Health Editor Michele Gershberg walks with her son Natan at a park in the Brooklyn borough...
New York, UNITED STATES
Reuters U.S. Health Editor Michele Gershberg walks with her son Natan at a park in New York
Reuters U.S. Health Editor Michele Gershberg walks with her son Natan at a park in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTX6I69R
December 11, 2018
Reuters U.S. Health Editor Michele Gershberg greets her son Natan in the Brooklyn borough of New York...
New York, UNITED STATES
Reuters U.S. Health Editor Michele Gershberg greets her son Natan in New York
Reuters U.S. Health Editor Michele Gershberg greets her son Natan in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NL
December 06, 2018
Reuters' U.S. Health Editor Michele Gershberg talks with her son Natan in a park in Brooklyn, New York...
New York, UNITED STATES
Reuters' U.S. Health Editor Michele Gershberg talks with her son Natan in a park in New York
Reuters' U.S. Health Editor Michele Gershberg talks with her son Natan in a park in Brooklyn, New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NJ
December 06, 2018
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, sits on a swing in a park in Brooklyn,...
New York, UNITED STATES
Natan, son of Reuters' U.S. Health Editor Michele Gershberg, sits on a swing in a park in New York
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, sits on a swing in a park in Brooklyn, New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NI
December 06, 2018
Michele Gershberg's son Natan is pictured at age one in New York, U.S. May 21, 2014. Picture taken May...
New York, UNITED STATES
Michele Gershberg's son Natan is pictured at age one in New York
Michele Gershberg's son Natan is pictured at age one in New York, U.S. May 21, 2014. Picture taken May 21, 2014. To match Special Report GENOMICS-TUMOR/ REUTERS/Michele Gershberg
GENOMICS-TUMOR/
RTS295NH
December 06, 2018
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, plays in Brooklyn, New York City, U.S.,...
New York, UNITED STATES
Natan, son of Reuters' U.S. Health Editor Michele Gershberg, plays in New York
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, plays in Brooklyn, New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NG
December 06, 2018
Natan is pushed on a swing by his mother, Reuters' U.S. Health Editor Michele Gershberg, in a park in...
New York, UNITED STATES
Natan is pushed on a swing by his mother, Reuters' U.S. Health Editor Michele Gershberg, in a park in...
Natan is pushed on a swing by his mother, Reuters' U.S. Health Editor Michele Gershberg, in a park in Brooklyn, New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NF
December 06, 2018
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, works on his homework in Brooklyn, New...
New York, UNITED STATES
Natan, son of Reuters' U.S. Health Editor Michele Gershberg, works on his homework in New York
Natan, the son of Reuters' U.S. Health Editor Michele Gershberg, works on his homework in Brooklyn, New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295ND
December 06, 2018
Dr. Matthias Karajannis speaks during an interview with Reuters' U.S. Health Editor Michele Gershberg...
New York, UNITED STATES
Dr. Karajannis speaks during an interview with Reuters' U.S. Health Editor Gershberg about her son at...
Dr. Matthias Karajannis speaks during an interview with Reuters' U.S. Health Editor Michele Gershberg about her son at Memorial Sloan Kettering Cancer Center in New York City, U.S., November 27, 2018. Picture taken November 27, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NC
December 06, 2018
Natan is given his medication from his mother, Reuters' U.S. Health Editor Michele Gershberg, in the...
New York, UNITED STATES
Natan is given his medication from his mother, Reuters' U.S. Health Editor Michele Gershberg, in New...
Natan is given his medication from his mother, Reuters' U.S. Health Editor Michele Gershberg, in the Brooklyn borough of New York City, U.S., November 19, 2018. Picture taken November 19, 2018. To match Special Report GENOMICS-TUMOR/ REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NB
December 06, 2018
Dr. Matthias Karajannis speaks during an interview with Reuters' U.S. Health Editor Michele Gershberg...
New York, UNITED STATES
Dr. Karajannis speaks during an interview with Reuters' U.S. Health Editor Gershberg about her son at...
Dr. Matthias Karajannis speaks during an interview with Reuters' U.S. Health Editor Michele Gershberg about her son at Memorial Sloan Kettering Cancer Center in New York City, U.S., November 27, 2018. Picture taken November 27, 2018. To match Special Report GENOMICS-TUMOR. REUTERS/Brendan McDermid
GENOMICS-TUMOR/
RTS295NA
December 06, 2018
Michele Gershberg's son Natan is pictured at age four in New York, U.S. March 12, 2017. Picture taken...
New York, UNITED STATES
Michele Gershberg's son Natan is pictured at age four in New York
Michele Gershberg's son Natan is pictured at age four in New York, U.S. March 12, 2017. Picture taken March 12, 2017. To match Special Report GENOMICS-TUMOR/ REUTERS/Michele Gershberg
HEALTH-CHINA/BABIES-PANEL
RTS27VES
November 28, 2018
Chinese Academy of Social Sciences Emeritus Professor Qiu Renzong speaks to the media during International...
Hong Kong, China
Chinese Academy of Social Sciences Emeritus Professor Qiu Renzong speaks to the media during International...
Chinese Academy of Social Sciences Emeritus Professor Qiu Renzong speaks to the media during International Summit on Human Genome Editing at the University of Hong Kong in Hong Kong, China November 28, 2018. REUTERS/Aleksander Solum
HEALTH-CHINA/BABIES-PANEL
RTS27VER
November 28, 2018
Scientist He Jiankui attends the International Summit on Human Genome Editing at the University of Hong...
Hong Kong, China
Scientist He Jiankui attends the International Summit on Human Genome Editing at the University of Hong...
Scientist He Jiankui attends the International Summit on Human Genome Editing at the University of Hong Kong in Hong Kong, China November 28, 2018. REUTERS/Holly Chik
CHINA-GERMANY/
RTS1T5VE
May 25, 2018
The logo of iCarbonX, a start up company focusing on combining genomics with other health factors to...
Shenzhen, China
The logo of start up company iCarbonX is displayed in Shenzhen
The logo of iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, is displayed in their office in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
CHINA-GERMANY/
RTS1T5US
May 25, 2018
Staff work behind a robot at iCarbonX, a start up company focusing on combining genomics with other health...
Shenzhen, China
Staff work at start up company iCarbonX in Shenzhen
Staff work behind a robot at iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
CHINA-GERMANY/
RTS1T5TE
May 25, 2018
Products are displayed at iCarbonX, a start up company focusing on combining genomics with other health...
Shenzhen, China
Products are displayed at start up company iCarbonX in Shenzhen
Products are displayed at iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
CHINA-GERMANY/
RTS1T5SZ
May 25, 2018
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with...
Shenzhen, China
German Chancellor Angela Merkel visits start up company iCarbonX in Shenzhen
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
CHINA-GERMANY/
RTS1T5SY
May 25, 2018
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with...
Shenzhen, China
German Chancellor Angela Merkel visits start up company iCarbonX in Shenzhen
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
CHINA-GERMANY/
RTS1T5RI
May 25, 2018
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with...
Shenzhen, China
German Chancellor Angela Merkel visits start up company iCarbonX in Shenzhen
German Chancellor Angela Merkel visits iCarbonX, a start up company focusing on combining genomics with other health factors to create a digitalized form of life, in Shenzhen, China May 25, 2018. REUTERS/Bobby Yip
ISRAEL-WHEAT/GENOME
RTSVVKM
January 17, 2017
Gil Ronen, Co-founder and CEO of NRGene, an Israeli genomic big data company, gestures during his interview...
GIVAT BRENNER, Israel
Guy Kol, Founder & VP of R&D of NRGene, an Israeli genomic big data company, poses for a picture in a...
Gil Ronen, Co-founder and CEO of NRGene, an Israeli genomic big data company, gestures during his interview with Reuters at a field in Givat Brenner, Israel January 8, 2017. Picture taken January 8, 2017. REUTERS/Baz Ratner
ISRAEL-WHEAT/GENOME
RTSVVKL
January 17, 2017
Guy Kol, Founder & VP of R&D of NRGene, an Israeli genomic big data company, poses for a picture in a...
Rehovot, Israel
Guy Kol, Founder & VP of R&D of NRGene, an Israeli genomic big data company, poses for a picture in a...
Guy Kol, Founder & VP of R&D of NRGene, an Israeli genomic big data company, poses for a picture in a laboratory in Rehovot, Israel January 8, 2017. Picture taken January 8, 2017. REUTERS/Baz Ratner
ISRAEL-WHEAT/GENOME
RTSVVKK
January 17, 2017
Omer Barad, CTO of NRGene, an Israeli genomic big data company, poses for a picture at the company offices...
NES TZIONA, Israel
Omer Barad, CTO of NRGene, an Israeli genomic big data company, poses for a picture at the compnay offices...
Omer Barad, CTO of NRGene, an Israeli genomic big data company, poses for a picture at the company offices in Rehovot, Israel January 8, 2017. Picture taken January 8, 2017. REUTERS/Baz Ratner
BRITAIN-EU/INDUSTRY
RTSSN4H
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-EU/INDUSTRY
RTSSN4G
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-EU/INDUSTRY
RTSSN4F
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-EU/INDUSTRY
RTSSN4E
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-POLITICS/
RTSSN3E
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-POLITICS/
RTSSN31
November 21, 2016
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November...
Cambridge, United Kingdom
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge
Britain's Prime Minister Theresa May visits the Wellcome Genome Campus in Cambridge, Britain November 21, 2016. REUTERS/Stefan Rouseau/Pool
BRITAIN-ROYALS/
RTX2SUUU
November 09, 2016
Senior scientist Aengus Stewart (L) and Sir Paul Nurse show Britain's Queen Elizabeth, a genome data...
London, United Kingdom
Senior scientist Aengus Stewart and Sir Paul Nurse show Britain's Queen Elizabeth, a genome data display...
Senior scientist Aengus Stewart (L) and Sir Paul Nurse show Britain's Queen Elizabeth, a genome data display during her visit to officially open the Francis Crick Institute in central London November 9, 2016. REUTERS/Nick Ansell/Pool
BRITAIN-ROYALS/
RTX2SUUQ
November 09, 2016
Sir Paul Nurse Director of the Francis Crick Institute watches as Britain's Queen Elizabeth pushes a...
London, United Kingdom
Sir Paul Nurse Director of the Francis Crick Institute watches as Britain's Queen Elizabeth pushes a...
Sir Paul Nurse Director of the Francis Crick Institute watches as Britain's Queen Elizabeth pushes a button to start sequencing Sir Paul's genome during a visit to officially open the Francis Crick Institute in central London November 9, 2016. REUTERS/Nick Ansell/Pool
SPAIN-ODDLY/
RTS5JBS
October 21, 2015
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the...
Oviedo, Spain
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the...
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the media during a visit to a painting exhibition by children about the genome, at the San Francisco park in Oviedo, October 21, 2015. Charpentier and Doudna will be awarded the 2015 Princess of Asturias Award for Technical and Scientific Research at a ceremony on Friday in the Asturian capital. The Princess of Asturias Awards have been held annually since 1981 to reward scientific, technical, cultural, social and humanitarian work done by individuals, teams and institutions. REUTERS/Eloy Alonso
SPAIN-ODDLY/
RTS5JBQ
October 21, 2015
French microbiologist Emmanuelle Charpentier (R) and professor Jennifer Doudna of the U.S. visit a painting...
Oviedo, Spain
French microbiologist Emmanuelle Charpentier (R) and professor Jennifer Doudna of the U.S. visit a painting...
French microbiologist Emmanuelle Charpentier (R) and professor Jennifer Doudna of the U.S. visit a painting exhibition by children about the genome, at the San Francisco park in Oviedo, October 21, 2015. Charpentier and Doudna will be awarded the 2015 Princess of Asturias Award for Technical and Scientific Research at a ceremony on Friday in the Asturian capital. The Princess of Asturias Awards have been held annually since 1981 to reward scientific, technical, cultural, social and humanitarian work done by individuals, teams and institutions. REUTERS/Eloy Alonso
SPAIN-ODDLY/
RTS5J2Q
October 21, 2015
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the...
Oviedo, Spain
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the...
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the media during a visit to a painting exhibition by children about the genome, at the San Francisco park in Oviedo, October 21, 2015. Charpentier and Doudna will be awarded the 2015 Princess of Asturias Award for Technical and Scientific Research at a ceremony on Friday in the Asturian capital. The Princess of Asturias Awards have been held annually since 1981 to reward scientific, technical, cultural, social and humanitarian work done by individuals, teams and institutions. REUTERS/Eloy Alonso
HEALTH-GENOMICS-CLOUD/ C
RTX1F558
June 04, 2015
HEALTH-GENOMICS-CLOUD/ - Graphic explaining how pharmaceutical researchers use Amazon web services to...
UNITED STATES
HEALTH-GENOMICS-CLOUD/ C
HEALTH-GENOMICS-CLOUD/ - Graphic explaining how pharmaceutical researchers use Amazon web services to store and analyze DNA sequences. (SIN14)
CANADA-POLITICS/
RTR4F33F
November 21, 2014
Genome scientist Thomas Hudson (L) poses with Governor General David Johnston after being awarded the...
Ottawa, Canada
Genome scientist Hudson poses with Governor General Johnston after being awarded the rank of Officer...
Genome scientist Thomas Hudson (L) poses with Governor General David Johnston after being awarded the rank of Officer in the Order of Canada during a ceremony at Rideau Hall in Ottawa November 21, 2014. REUTERS/Chris Wattie (CANADA - Tags: POLITICS SCIENCE TECHNOLOGY)
HEALTH-SEQUENCING/
RTR3UNB9
June 19, 2014
Joe Smith plays with his daughter Rowan at a playground in Winthrop Harbor, Illinois, May 9, 2014. Three...
WINTHROP HARBOR, UNITED STATES
Joe Smith plays with his daughter Rowan at a playground in Winthrop Harbor, Illinois
Joe Smith plays with his daughter Rowan at a playground in Winthrop Harbor, Illinois, May 9, 2014. Three of his children have been diagnosed with atypical Hemolytic Uremic Syndrome, and one is a carrier which was diagnosed using genome sequencing. Once strictly the domain of research labs, gene-sequencing tests increasingly are being used to help understand the genetic causes of rare disease, putting insurance companies in the position of deciding whether to pay the $5,000 to $17,000 for the tests. Genetics experts say that sequencing more than doubles the chances that families get a diagnosis, and saves spending on multiple tests of single genes. Even if no treatment is found, the tests can also end hugely expensive medical odysseys as parents frantically search for the cause of their child's furtive illness. Picture taken May 9, 2014. To match Insight HEALTH-SEQUENCING/ REUTERS/Jim Young (UNITED STATES - Tags: SCIENCE TECHNOLOGY HEALTH SOCIETY BUSINESS)
HEALTH-SEQUENCING/
RTR3UNAO
June 19, 2014
Joe Smith rides on a swing with his daughter Rowan as his wife Andrea plays with her children Norah and...
WINTHROP HARBOR, UNITED STATES
Joe Smith rides on a swing with his daughter Rowan as his wife Andrea plays with her children Norah and...
Joe Smith rides on a swing with his daughter Rowan as his wife Andrea plays with her children Norah and Chase at a playground in Winthrop Harbor, Illinois, May 9, 2014. Three of their children have been diagnosed with atypical Hemolytic Uremic Syndrome, and one is a carrier which was diagnosed using genome sequencing. Once strictly the domain of research labs, gene-sequencing tests increasingly are being used to help understand the genetic causes of rare disease, putting insurance companies in the position of deciding whether to pay the $5,000 to $17,000 for the tests. Genetics experts say that sequencing more than doubles the chances that families get a diagnosis, and saves spending on multiple tests of single genes. Even if no treatment is found, the tests can also end hugely expensive medical odysseys as parents frantically search for the cause of their child's furtive illness. Picture taken May 9, 2014. To match Insight HEALTH-SEQUENCING/ REUTERS/Jim Young (UNITED STATES - Tags: SCIENCE TECHNOLOGY HEALTH SOCIETY BUSINESS)
HEALTH-SEQUENCING/
RTR3UNA9
June 19, 2014
Joe Smith plays with his daughter Norah as his son Chase looks on at a playground in Winthrop Harbor,...
WINTHROP HARBOR, UNITED STATES
Joe Smith plays with his daughter Norah as his son Chase looks on at a playground in Winthrop Harbor,...
Joe Smith plays with his daughter Norah as his son Chase looks on at a playground in Winthrop Harbor, Illinois, May 9, 2014. Three of his children have been diagnosed with atypical Hemolytic Uremic Syndrome, and one is a carrier which was diagnosed using genome sequencing. Once strictly the domain of research labs, gene-sequencing tests increasingly are being used to help understand the genetic causes of rare disease, putting insurance companies in the position of deciding whether to pay the $5,000 to $17,000 for the tests. Genetics experts say that sequencing more than doubles the chances that families get a diagnosis, and saves spending on multiple tests of single genes. Even if no treatment is found, the tests can also end hugely expensive medical odysseys as parents frantically search for the cause of their child's furtive illness. Picture taken May 9, 2014. To match Insight HEALTH-SEQUENCING/ REUTERS/Jim Young (UNITED STATES - Tags: SCIENCE TECHNOLOGY HEALTH SOCIETY BUSINESS)
Sort by
Display
Items per page
Page
of 6